首页> 中文期刊> 《中国医学创新》 >血清SP-A联合SP-D检测对于肺泡蛋白沉积症患者诊断的临床价值探讨

血清SP-A联合SP-D检测对于肺泡蛋白沉积症患者诊断的临床价值探讨

         

摘要

目的:探讨血清SP-A联合SP-D检测对于肺泡蛋白沉积症(PAP)患者诊断的临床价值。方法:选择2014年11月-2015年2月本院呼吸内科收治的PAP患者40例作为试验组,另选本院体检中心接待的40名健康人作为对照组,比较两组血清中SP-A、SP-D的浓度。结果:试验组血清中SP-A、SP-D浓度均高于对照组,比较差异均有统计学意义(P<0.05)。结论:SP-A与SP-D在检测患者是否发生PAP方面具有一定的辅助诊断价值。%Objective: To investigate the clinical value of serum SP-A and SP-D detection for pulmonary alveolar proteinosis(PAP).Method:40 patients with PAP in the respiration medicine of our hospital from November 2014 to February 2015 were selected as the experimental group,40 healthy people in the physical examination center of our hospital were selected as the control group.The concentrations of serum SP-D and SP-A were compared between the two groups.Result:The concentrations of serum SP-D and SP-A in the experimental group were higher than those in the control group,the differences were statistically significant(P<0.05). Conclusion:SP-A and SP-D have certain auxiliary diagnostic value in the detection of PAP.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号